Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Apogenix raises €27.5mm through Series B round

Executive Summary

Protein therapeutics start-up Apogenix GMBH has raised €27.5mm ($43mm) through its Series B round. Dievini Hopp Biotech Holding (managed by Dievini GMBH, the investment company of Dietmar Hopp) was the lead backer.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Large Molecule
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies